Annual Drug Patent Expirations for LAZANDA
Lazanda is a drug marketed by Btcp Pharma and is included in one NDA. There are five patents protecting this drug.
This drug has fifty-three patent family members in thirty countries.
The generic ingredient in LAZANDA is fentanyl citrate. Additional details are available on the fentanyl citrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
